Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06053307 · ClinicalTrials.gov registry record · NA
Treating Psychosocial Distress in Glaucoma
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT06053307 is a NA study that has completed, run by Duke University. The registered enrollment target is 28 participants.
The verdict
NCT06053307, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
In this study, using three phases, the investigators will use an iterative development approach to refine a behavioral intervention for managing concomitant psychosocial distress in glaucoma. Phase 1: The investigators will begin by developing a baseline intervention using strategies from Acceptance and Commitment Therapy (ACT), and delivered using a mobile application. Phase 2: The investigators will refine the baseline intervention for glaucoma patients using qualitative interviews conducted with primary open-angle glaucoma (POAG) patients with psychosocial distress (N=20), and health professionals (N=5). Phase 3: Finally, the investigators will measure acceptability and feasibility of the refined intervention through a single-armed pilot study (N=25). The investigators hypothesize that the refined intervention will yield an acceptable and feasible intervention in a POAG patient population, setting the stage for a future efficacy study.
Interventions
- BEHAVIORAL Acceptance commitment therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2025-04-01 |
| Est. Completion | 2026-01-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06053307
The ClinicalTrials.gov registry entry for NCT06053307 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Acceptance commitment therapy is the first listed.
NCT06053307 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06053307 about?
NCT06053307 is a clinical study titled "Treating Psychosocial Distress in Glaucoma". In this study, using three phases, the investigators will use an iterative development approach to refine a behavioral intervention for managing concomitant psychosocial distress in glaucoma. Phase 1: The investigators will begin by developing a baseline intervention using strategies from Acceptance...
What is the current status of trial NCT06053307?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2025-04-01. Estimated completion is 2026-01-26.
What interventions are being tested in trial NCT06053307?
The interventions under investigation include: Acceptance commitment therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT06053307?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.